{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:28:59Z","timestamp":1777645739769,"version":"3.51.4"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":5540,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,7]]},"DOI":"10.1046\/j.1365-2133.2000.03607.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T05:28:57Z","timestamp":1047360537000},"page":"157-161","source":"Crossref","is-referenced-by-count":40,"title":["Rituximab in cutaneous B-cell lymphoma: a report of two cases"],"prefix":"10.1093","volume":"143","author":[{"given":"R.A.","family":"Sabroe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.J.","family":"Child","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.J.","family":"Woolford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.F.","family":"Spittle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Russell-Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1524-4725.1989.tb03618.x","article-title":"B-cell lymphoma","volume":"15","author":"McNutt","year":"1989","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB2","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/archderm.1995.01690210109021","article-title":"New concepts in the classification of cutaneous lymphomas","volume":"131","author":"Willemze","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB3","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/1097-0142(19910501)67:9<2311::AID-CNCR2820670918>3.0.CO;2-0","article-title":"Primary cutaneous B-cell lymphoma: a unique type of low-grade lymphoma","volume":"67","author":"Santucci","year":"1991","journal-title":"Cancer"},{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB4","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0950-3536(96)80052-7","article-title":"Management of cutaneous lymphoma","volume":"9","author":"Russell-Jones","year":"1996","journal-title":"Bailli\u00e8re\u2019s Clin Haematol"},{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB5","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1001\/archderm.1996.03890350042008","article-title":"Primary cutaneous large B-cell lymphomas of the legs","volume":"132","author":"Vermeer","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB6","first-page":"345","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1046\/j.1365-2133.1998.02547.x","article-title":"Primary cutaneous B-cell lymphoma: How useful is the new European Organization for Research and Treatment of Cancer (EORTC) classification?","volume":"139","author":"Russell-Jones","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB8","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","article-title":"Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program","volume":"16","author":"McLaughlin","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB9","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1182\/blood.V90.6.2188","article-title":"IDEC-C2B8 (rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin\u2019s lymphoma","volume":"90","author":"Maloney","year":"1997","journal-title":"Blood"},{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00001622-199811000-00012","article-title":"Use of rituximab, the new FDA-approved antibody","volume":"10","author":"Leget","year":"1998","journal-title":"Curr Opin Oncol"},{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB11","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V83.2.435.435","article-title":"Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20","volume":"83","author":"Reff","year":"1994","journal-title":"Blood"},{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB12","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1182\/blood.V63.6.1424.1424","article-title":"Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation","volume":"63","author":"Anderson","year":"1984","journal-title":"Blood"},{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB13","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0167-5699(94)90276-3","article-title":"CD20: a regulator of cell-cycle progression of B lymphocytes","volume":"15","author":"Tedder","year":"1994","journal-title":"Immunol Today"},{"issue":"Suppl.","key":"10.1046\/j.1365-2133.2000.03607.x-BIB14","first-page":"637a","article-title":"The anti-tumour effect of monoclonal anti-CD20 antibody (mAb) therapy includes direct anti-proliferative activity and induction of apoptosis in CD20 positive non-Hodgkin\u2019s lymphoma (NHL) cell lines","volume":"88","author":"Maloney","year":"1996","journal-title":"Blood"},{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1200\/JCO.1992.10.1.28","article-title":"Activity of fludarabine in previously treated non-Hodgkin\u2019s low-grade lymphoma: results of an Eastern cooperative oncology group study","volume":"10","author":"Hochster","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB16","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1200\/JCO.1994.12.4.788","article-title":"2-chlorodeoxyadenosine is an active salvage therapy in advanced indolent non-Hodgkin\u2019s lymphoma","volume":"12","author":"Hoffman","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB17","unstructured":"17\u2002Anonymous . Rituximab (MabThera): serious infusion-related adverse reactions. Current problems in pharmacovigilance, London: Committee on Safety of Medicines and the Medicines Control Agency, 1999; 25 (February): 2 3."},{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1200\/JCO.1999.17.3.791","article-title":"Rituximab therapy in hematologic malignancy patients with circulating blood tumour cells: association with increased infusion-related side effects and rapid blood tumor clearance","volume":"17","author":"Byrd","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB19","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1038\/sj.onc.1202591","article-title":"Bcl-2 family proteins","volume":"17","author":"Reed","year":"1998","journal-title":"Oncogene"},{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB20","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1126\/science.281.5381.1322","article-title":"The Bcl-2 protein family: arbiters of cell survival","volume":"281","author":"Adams","year":"1998","journal-title":"Science"},{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood.V87.1.265.265","article-title":"Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin\u2019s lymphoma","volume":"87","author":"Hermine","year":"1996","journal-title":"Blood"},{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB22","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/blood.V88.3.1046.1046","article-title":"Prognostic significance of bcl-2 expression and bcl-2 major breakpoint region rearrangement in diffuse large cell non-Hodgkin\u2019s lymphoma: a British National Lymphoma Investigation study","volume":"88","author":"Hill","year":"1996","journal-title":"Blood"},{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB23","first-page":"1927","article-title":"Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicentre phase II study","volume":"92","author":"Coiffier","year":"1998","journal-title":"Blood"},{"key":"10.1046\/j.1365-2133.2000.03607.x-BIB24","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1200\/JCO.1997.15.10.3266","article-title":"IDEC-C2B8: results of a phase I multiple-dose trial in patients with relapsed non-Hodgkin\u2019s lymphoma","volume":"15","author":"Maloney","year":"1997","journal-title":"J Clin Oncol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2133.2000.03607.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1046\/j.1365-2133.2000.03607.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T12:29:51Z","timestamp":1676377791000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/143\/1\/157\/6688032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,7]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2133.2000.03607.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,7]]}}}